Building novel binding ligands to B7.1 and B7.2 based on human antibody single variable light chain domains

Journal of Molecular Biology

Volumn 310, Issue 3, 2001, Pages 591-601

  Van Den Beucken, Twan ^a   Van Neer, Nicole ^a   Sablon, Erwin ^b   Desmet, Johan ^c   Celis, Linda ^b   Hoogenboom, Hennie R ^a   Hufton, Simon E ^a  

^a Dyax BV   (Netherlands)

^b INNOGENETICS   (Belgium)

^c UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

B7.1; B7.2; CTLA 4; Phage display; Single VL domains

Indexed keywords

B7 ANTIGEN; CD86 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; IMMUNOGLOBULIN LIGHT CHAIN;

ANTIGEN RECOGNITION; ARTICLE; BINDING AFFINITY; DRUG DESIGN; ESCHERICHIA COLI; IMMUNOMODULATION; MUTATION; NONHUMAN; PHAGE DISPLAY; PRIORITY JOURNAL; SEQUENCE ANALYSIS;

ESCHERICHIA COLI;

EID: 0035854524     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmbi.2001.4703     Document Type: Article

References (41)

1. CD28/B7 system of T-cell costimulation
2. CD28 engagement by B7/BB-1 induces transient down-regulation of CD28 synthesis and prolonged unresponsiveness to CD28 signaling
3. The role of the CD28 receptor during T-cell responses to antigen
4. Enhancement of antitumor immunity by CTLA-4 blockade
5. Negative regulation of T-cell activation
6. Long-term survival of xenogeneic pancreatic islet grafts induced by CTLA-4.1g
7. Treatment of murine lupus with CTLA.4-Ig
8. Inhibition of T-cell costimulation abrogates airway hyperresponsiveness in a murine model
9. CTLA-4 is a second receptor for the B cell activation antigen B7
10. Covalent dimerization of CD28/CTLA-4 and oligomerization of CD80/CD86 regulate T-cell costimulatory interactions
11. CD80 (B7-1) binds both CD28 and CTLA-4 with a low affinity and very fast kinetics
12. Complete blockade of B7 family-mediated costimulation is necessary to induce human alloantigen-specific anergy: A method to ameliorate graft- versus-host disease and extend the donor pool
13. Binding activities of a repertoire of single immunoglobulin variable domains secreted from Escherichia coli
14. Naturally occurring antibodies devoid of light chains
15. Antibody VH domains as small recognition units
16. An antibody single-domain phage display library of a native heavy chain variable region: Isolation of functional single-domain VH molecules with a unique interface
17. Domain libraries: Synthetic diversity for de novo desing of antibody V regions
18. Somatic generation of antibody diversity
19. The dynamic nature of the antibody repertoire
20. Complementarity determining region 1 (CDR1)- and CDR3-analogous regions in CTLA-4 and CD28 determine the binding to to B7-1
21. Solution structure of human CTLA-4 and delineation of a CD80/CD86 binding site conserved in CD28
22. Natural and designer binding sites made by phage display technology
23. Rapid evolution of a protein in vitro by DNA shuffling
24. A new member of the immunoglobulin superfamily-CTLA-4
25. A large non immunized human fab fragment phage library that permits rapid isolation and kinetic analysis of high affinity antibodies
26. Theoretical studies of clonal selection: Minimial antibody repertoire size and reliability of self non-self discrimination
27. Direct selection of a human antibody fragment directed against the tumor T-cell epitope HLA-A1-MAGE-A1 from a nonimmunized phage-Fab library
28. Development and application of cytotoxic T lymphocyte-associated antigen 4 as a protein scaffold for the generation of novel binding ligands
29. Camel single-domain antibodies as modular building units
30. Interactions of CD80 and CD86 with CD28 and CTLA4
31. Recombinant antibody fragments
32. Redefining the minimal antiger-binding fragment
33. Rapid tumor penetration of a single-chain Fv and comparison with other immunoglobulin forms
34. In vivo fate of monoclonal antibody B72.3 in patients with colorectal cancer
35. Replicative adenoviruses for cancer therapy
36. Intrabody construction and expression. II. A synthetic catalytic Fv fragment
37. Intrabody construction and expression. I. The critical role of VL domain stability
38. The selection of intracellular antibodies
39. Protein and antibody arrays and their medical applications
40. By-passing immunization: Human antibodies from V-gene libraries displayed on phage